Catalyst Biosciences
AcquiredGyre Therapeutics – Focused on organ fibrosis and inflammatory disease
Catalyst Biosciences was founded in 2000, is headquartered in South San Francisco, United States, lists 11–50 employees, and has $100.4M in recorded funding across 3 rounds.
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2000
- Business Model
- B2B
- Website
- catalystbiosciences.com
- Total Funding
- $100.4M
- Last Round
- $30.0M Corporate RoundJan 2011
- Rounds
- 3
- Acquisition Date
- Oct 2023
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.
About
Catalyst Biosciences was a South San Francisco-based biopharmaceutical company focused on developing protein therapeutics for rare bleeding disorders including hemophilia. In 2023, GC Biopharma acquired Catalyst's rare hematology pipeline assets while Catalyst completed a reverse merger with GNI Group's Beijing Continent Pharmaceuticals, pivoting to fibrosis treatments.
Summary
Catalyst Biosciences is a Biotech company based in South San Francisco, United States, founded in 2000. It lists 11–50 employees. It has raised $100.4M in total across 3 rounds, most recently a $30.0M Corporate Round in Jan 2011. Investors include Essex Woodlands Health Ventures, Burrill & Company and HealthCare.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Oct 2023
Sign up to see all 6 events
Funding: Series B through Corporate Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/catalyst-biosciences"><img src="https://indexed.vc/api/badge/company/catalyst-biosciences" alt="Catalyst Biosciences on Indexed.vc" width="260" height="76" /></a>